MEK activation is associated with a molecular subgroup in high grade serous ovarian cancer

被引：0
|
作者：
McCabe, Nuala
Gourley, Charlie
McGavigan, Andrena
Michie, Caroline .
McGivern, Niamh
Churchman, Michael
O'Brien, Eamonn J.
Hill, Laura
Davison, Timothy S.
Williams, Alistair
McCluggage, Glenn
Keating, Karen E.
Harkin, Denis P.
Kennedy, Richard D.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-453
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
453
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Integrated Analysis To Identify Molecular Biomarkers Of High-Grade Serous Ovarian Cancer
    Si, Manfei
    Zhang, Junji
    Cao, Jianzhong
    Xie, Zhibo
    Shu, Shan
    Zhu, Yapei
    Lang, Jinghe
    ONCOTARGETS AND THERAPY, 2019, 12 : 10057 - 10075
  • [22] Cyclooxygenase-1 as a target for molecular imaging of high grade serous ovarian cancer
    Wilson, Andrew J.
    Lehmann, Brian D.
    Ussin, M. D. Jashim
    Elleman, Anna
    Crews, Brenda
    Saskowski, Jeanette
    Pietenpol, Jennifer
    Marnett, Lawrence J.
    Khabele, Dineo
    CANCER RESEARCH, 2014, 74 (19)
  • [23] Molecular classification and immunologic characteristics of immunoreactive high-grade serous ovarian cancer
    Liu, Zheran
    Wu, Haifang
    Deng, Jiachen
    Wang, Haoqing
    Wang, Zixuan
    Yang, Ailin
    Liang, Bowen
    Luo, Ji
    Li, Jianyong
    Xu, Yanmei
    Tang, Xiaoli
    Fu, Fen
    Deng, Libin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (14) : 8103 - 8114
  • [24] Molecular analysis of exceptional response in high-grade serous ovarian cancer.
    Garsed, Dale
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje
    Saner, Flurina
    Kennedy, Catherine
    Pearce, Celeste
    Pike, Malcolm
    Ramus, Susan
    Kobel, Martin
    deFazio, Anna
    Goode, Ellen
    Nelson, Brad
    Bowtell, David
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 18
  • [25] Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer
    Lee, Sanghoon
    Zhao, Li
    Rojas, Christine
    Bateman, Nicholas W.
    Yao, Hui
    Lara, Olivia D.
    Celestino, Joseph
    Morgan, Margaret B.
    Nguyen, Tri V.
    Conrads, Kelly A.
    Rangel, Kelly M.
    Dood, Robert L.
    Hajek, Richard A.
    Fawcett, Gloria L.
    Chu, Randy A.
    Wilson, Katlin
    Loffredo, Jeremy L.
    Viollet, Coralie
    Jazaeri, Amir A.
    Dalgard, Clifton L.
    Mao, Xizeng
    Song, Xingzhi
    Zhou, Ming
    Hood, Brian L.
    Banskota, Nirad
    Wilkerson, Matthew D.
    Te, Jerez
    Soltis, Anthony R.
    Roman, Kristin
    Dunn, Andrew
    Cordover, David
    Eterovic, Agda Karina
    Liu, Jinsong
    Burks, Jared K.
    Baggerly, Keith A.
    Fleming, Nicole D.
    Lu, Karen H.
    Westin, Shannon N.
    Coleman, Robert L.
    Mills, Gordon B.
    Casablanca, Yovanni
    Zhang, Jianhua
    Conrads, Thomas P.
    Maxwell, George L.
    Futreal, P. Andrew
    Sood, Anil K.
    CELL REPORTS, 2020, 31 (02):
  • [26] Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
    Konecny, Gottfried E.
    Wang, Chen
    Hamidi, Habib
    Winterhoff, Boris
    Kalli, Kimberly R.
    Dering, Judy
    Ginther, Charles
    Chen, Hsiao-Wang
    Dowdy, Sean
    Cliby, William
    Gostout, Bobbie
    Podratz, Karl C.
    Keeney, Gary
    Wang, He-Jing
    Hartmann, Lynn C.
    Slamon, Dennis J.
    Goode, Ellen L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (10):
  • [27] MEK Inhibition Aids in Serous Ovarian Cancer
    不详
    CANCER DISCOVERY, 2012, 2 (05)
  • [28] Immune cell landscapes are associated with high-grade serous ovarian cancer survival
    Zhang, Guoan
    Zhang, Yan
    Zhang, Jingjing
    Yang, Xiaohui
    Sun, Wenjie
    Liu, Ying
    Liu, Yingfu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [29] Certain fusion genes are associated with clinical outcomes in high grade serous ovarian cancer
    Newtson, Andreea Mihai
    Reyes, Henry D.
    Lyons, Yasmin A.
    Devor, Eric
    Goodheart, Michael Joseph
    Gonzalez-Bosquet, Jesus
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E12 - E12
  • [30] Clonality and loss of heterozygosity are associated with prognosis and subtypes in high grade serous ovarian cancer
    Takaya, Hisamitsu
    Nakai, Hidekatsu
    Sakai, Kazuko
    Nishio, Kazuto
    Matsumura, Noriomi
    CANCER SCIENCE, 2018, 109 : 640 - 640
12345